Cargando…
MicroRNA‐495‐3p diminishes doxorubicin‐induced cardiotoxicity through activating AKT
Doxorubicin (Dox) is a broad‐spectrum antitumour agent; however, its clinical application is impeded due to the cumulative cardiotoxicity. The present study aims to investigate the role and underlying mechanisms of microRNA‐495‐3p (miR‐495‐3p) in Dox‐induced cardiotoxicity. Herein, we found that car...
Autores principales: | Meng, Jun, Xu, Can |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8980898/ https://www.ncbi.nlm.nih.gov/pubmed/35152537 http://dx.doi.org/10.1111/jcmm.17230 |
Ejemplares similares
-
MicroRNA in the Diagnosis and Treatment of Doxorubicin-Induced Cardiotoxicity
por: Kuang, Ziyu, et al.
Publicado: (2023) -
MicroRNA-34a regulates doxorubicin-induced cardiotoxicity in rat
por: Piegari, Elena, et al.
Publicado: (2016) -
MicroRNAs in doxorubicin-induced cardiotoxicity: The DNA damage response
por: Kawano, Ippei, et al.
Publicado: (2022) -
Toll-like receptor 5 deficiency diminishes doxorubicin-induced acute cardiotoxicity in mice
por: Ma, Zhen-Guo, et al.
Publicado: (2020) -
MicroRNA-495 induces breast cancer cell migration by targeting JAM-A
por: Cao, Minghui, et al.
Publicado: (2014)